Arena Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, or GPCRs, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.
Wednesday, October 6, 2010
Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
No comments:
Post a Comment